Gibson Dunn, Latham & Watkins aid in Allergan's $958 million purchase
Gibson, Dunn & Crutcher LLP represented Irvine-based Allergan Inc. in its agreement to purchase Map Pharmaceuticals Inc. for $958 million, or $25 a share.
Irvine-based partner Terrence R. Allen and Palo Alto-based partner Gregory T. Davidson co-led the Gibson Dunn team.
Latham & Watkins LLP advised Map Pharm...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In